Prestige Consumer Healthcare
Stock Forecast, Prediction & Price Target

Prestige Consumer Healthcare (PBH) stock Price Target by analysts

Last Year
Average Price Target

$86

Potential upside: 28.91%

Based on 1 analysts

Prestige Consumer Healthcare price prediction

Strike.market

What is Prestige Consumer Healthcare stock analysts` prediction?

Prestige Consumer Healthcare stock forecast: Based on 1 Wall Street analysts` predicted price targets for Prestige Consumer Healthcare in the last 3 months, the avarage price target is $86, with a high forecast of $NaN. The average price target represents a 28.91% change from the last price of $66.71.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Prestige Consumer Healthcare stock Price Target by analysts

Full breakdown of analysts given Prestige Consumer Healthcare price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Susan Anderson
Canaccord Genuity
0%
0/1
10 months ago $86 28.91% upside $74.58 StreetInsider
Previous targets (0)
Linda Bolton Weiser
D.A. Davidson
0%
0/1
about 1 year ago $93 39.40% upside $68.13 StreetInsider
Previous targets (0)
Unknown
Canaccord Genuity
N/A
almost 3 years ago $71 6.43% upside $58.35 Benzinga
N/A

Prestige Consumer Healthcare Financial Estimates

Prestige Consumer Healthcare Revenue Estimates

Prestige Consumer Healthcare EBITDA Estimates

Prestige Consumer Healthcare Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2022 3/31/2023 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
$1.08B
 
N/A
$1.12B
 
3.76%
$1.12B
 
-0.20%
Avg: $1.15B
Low: $1.15B
High: $1.16B
avg. 2.80%
Avg: $1.18B
Low: $1.18B
High: $1.19B
avg. 2.42%
Net Income
 
% change YoY
$205.38M
 
N/A
$-82.30M
 
-140.07%
$209.33M
 
354.34%
Avg: $234.55M
Low: $230.81M
High: $240.85M
avg. 12.04%
Avg: $236M
Low: $238.99M
High: $241.20M
avg. 0.61%
EBITDA
 
% change YoY
$360.95M
 
N/A
$14.18M
 
-96.07%
$373.86M
 
2535.60%
Avg: $388.42M
Low: $387.36M
High: $391.80M
avg. 3.89%
Avg: $397.85M
Low: $396.77M
High: $399.59M
avg. 2.42%
EPS
 
% change YoY
$4.09
 
N/A
-$1.65
 
-140.34%
$4.21
 
355.15%
Avg: $4.7
Low: $4.6
High: $4.8
avg. 11.55%
Avg: $4.78
Low: $4.76
High: $4.81
avg. 1.77%
Operating Expenses
 
% change YoY
$290.72M
 
N/A
$277.49M
 
-4.55%
$282.01M
 
1.63%
Avg: $273.97M
Low: $273.22M
High: $276.35M
avg. -2.85%
Avg: $280.63M
Low: $279.86M
High: $281.85M
avg. 2.42%

FAQ

What is Prestige Consumer Healthcare stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 6.33% in 2026-2027.

We have gathered data from 5 analysts. Their low estimate is 230.81M, average is 234.55M and high is 240.85M.

What is Prestige Consumer Healthcare stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 2.61% in 2026-2027.

We have gathered data from 5 analysts. Their low revenue estimate is $1.15B, average is $1.15B and high is $1.16B.

What is Prestige Consumer Healthcare stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 6.66% in 2026-2027.

We have gathered data from 5 analysts. Their low earnings per share estimate is $4.6, average is $4.7 and high is $4.8.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Prestige Consumer Healthcare stock. The most successful analyst is Susan Anderson.